首页> 外文期刊>Frontiers in Laboratory Medicine >Autophagy: A new target for the treatment of atherosclerosis
【24h】

Autophagy: A new target for the treatment of atherosclerosis

机译:自噬:动脉粥样硬化治疗的新目标

获取原文
       

摘要

Atherosclerosis remains one of the main causes of death in both developed and developing countries, leading to acute cardiovascular events and chronic injuries. Atherosclerosis is a multifactorial disease, and several studies have demonstrated that autophagy plays an important role in the occurrence and development of atherosclerosis. Autophagy is an evolutionarily conserved cellular process by which misfolded proteins and excessive or dysfunctional organelles are degraded to maintain energy homeostasis. There is increasing evidence that autophagy can be activated in cardiovascular diseases such as atherosclerosis, especially macrophage autophagy. As the molecular mechanism of autophagy is complicated, the regulation of atherosclerosis is varied. Understanding the types of autophagy regulating factors may provide clues for the treatment of atherosclerosis. In this review, the role of autophagy in atherosclerosis and the current understanding of the association between autophagy and atherosclerosis were investigated. Moreover, the regulation of autophagy by mTOR inhibitors, as well as natural ingredients such as resveratrol and berberine was elucidated.
机译:在发达国家和发展中国家,动脉粥样硬化仍然是主要的死亡原因之一,导致急性心血管事件和慢性伤害。动脉粥样硬化是一种多因素疾病,一些研究表明自噬在动脉粥样硬化的发生和发展中起重要作用。自噬是一种进化上保守的细胞过程,通过该过程,错误折叠的蛋白质和过多或功能异常的细胞器被降解,以维持能量稳态。越来越多的证据表明自噬可以在诸如动脉粥样硬化的心血管疾病中被激活,尤其是巨噬细胞自噬。由于自噬的分子机制复杂,因此动脉粥样硬化的调节也不同。了解自噬调节因子的类型可能为动脉粥样硬化的治疗提供线索。在这篇综述中,研究了自噬在动脉粥样硬化中的作用以及对自噬与动脉粥样硬化之间关系的当前理解。此外,阐明了mTOR抑制剂以及白藜芦醇和小ber碱等天然成分对自噬的调节作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号